Table 3 shows the multivariable-adjusted hazard ratios for various causes of mortality including breast cancer, all-cause, all-noncancer, all-cancer, and all cancer other than breast cancer with regard to 2 cutoffs of duration of insulin use at 3 years and 5 years, respectively, in the whole cohort analyses and in the subgroup analyses. The gene discussed is INS; the disease is cancer.